CClinicalTrials.gg
TerminatedNCT00598494Updated Jan 27, 2017

Effect of Bedrest With and Without Exercise on the Heart

An observational study in Bedrest, sponsored by The Cleveland Clinic. Terminated at 1 site in United States. Open to participants aged 18 Years and older, including healthy volunteers. Per ClinicalTrials.gov, last updated 2017-01-27.

Sponsored by The Cleveland Clinic · Observational

Why this study was terminated
Main bedrest study moved to Texas. No enrollment at Cleveland Clinic.
Study type
Observational
Model
Case-only
Time perspective
Prospective
Enrollment
6
Ages
18 Years and older
Sex
All
01

Study summary

The purpose of this research sub-study is to determine the changes in heart function during the bedrest period using ultrasound and MRI. This topic is important for medical care of astronauts in space. It can enable physicians on the ground to monitor exercise protocols that are used to prevent deconditioning-loss of strength during long space flights.

Your participation in this study would include ultrasound examinations with bicycle exercise before, during, and after the 12-week bedrest period. MRI exams would be performed before and after the bedrest period.

Each echo exam may last up to 1 hour. This time will be required to perform an ultrasound examination before and during supine (lying down) bicycle exercise. The exercise period will be approximately 10-15 minutes. The bicycle exercise will be a symptom-limited test. This means that the test will be stopped if you experience any discomfort. An ultrasound examination of your heart will be done to assess heart function. You will be asked to lie on your left side on an examination table while a technician takes pictures of your heart with a small probe that is gently pressed against your chest after applying a gel. The ultrasound data will be processed to evaluate myocardial strain, a value that may be useful in describing heart function.

Each MRI may last up to 1 hour. An MRI obtains body pictures created by using magnetic energy rather than x-ray energy. To have the scan, you will lie on a table that slides into the scanner, which is like a large tube. An MRI examination of your heart will be done to assess heart function. You will be asked to lie still and follow simple breathing instructions during the procedure. The MRI data will be processed to evaluate the volume of blood being pumped by your heart, a value that may be useful in describing heart function.

Read the detailed description

NASA and NSBRI are making considerable investment in a bedrest study being conducted at the Cleveland Clinic Foundation under the directorship of Peter Cavanaugh, primarily to assess the impact of exercise on prevention of osteoporosis in a twelve-week bedrest study to simulate microgravity. This provides an outstanding opportunity for synergistic add-on studies to combine the resources of the bone team of NSBRI with those of the Cardiovascular Alterations and Smart Medicine by conducting a series of detailed echocardiographic and computed tomographic examinations of the heart in these patients. These studies will serve to advance a number of the specific aims of a grant currently held by James D. Thomas from NSBRI concerning both the primary effects of microgravity on the heart and its reversal with exercise as well as the ability to prove out new echocardiographic methods for measuring the cardiac response to exercise. Finally, they will provide an excellent opportunity to prove out methodologies being developed for remote delivery of healthcare by image fusion from free-flight studies to in-flight echoes.

We will to pursue the following specific aims with this synergistic study:

Specific Aim 1: To assess the impact of bedrest on cardiac atrophy, stiffening of the left ventricular diastolic pressure volume curve, and exercise tolerance and ventricular mechanics and demonstrate at least partial prevention of these changes with the proposed exercise prescription.

Specific Aim 2: To demonstrate the ability of novel echocardiographic indices of ventricular function (strain, torsion, IVPG) to predict functional capacity and response to exercise.

Specific Aim 3: To test whether pre-bedrest MRI examinations could be co-registered with bedrest 3D echocardiographic exams to track atrophy and altered cardiac anatomy. The ability of detailed 3D ground examinations to be compared precisely with in-flight 3D echos is a key goal of autonomous medical care system for expedition class missions.

Proposed Protocol (summary):

Pre-bedrest (within 1-3 weeks prior):

  1. Resting two and three-dimensional echocardiogram.
  2. Maximal supine bicycle test with echocardiographic assessment of wall motion, tissue strain, tissue torsion, and intraventricular pressure gradients (IVPG) by color M-mode flow propagation. In addition to the peak exercise assessment, we will also focus on the submaximal level (heart rate \~100).
  3. MRI examination of the heart for LV volume and mass and subsequent cross registration with echocardiogram.

Six weeks of bedrest:

  1. Resting two and three-dimensional echo exam.
  2. Low-level supine bicycle exercise echo (HR no greater than 100) with torsion, strain, and IVPG assessment.

Twelve weeks of bedrest:

  1. Resting two and three-dimensional echo.
  2. Maximal supine bicycle test with echocardiographic assessment of wall motion, tissue strain, tissue torsion, and IVPG.
  3. MRI examination of the heart.

As part of the overall bedrest protocol (IRB 6504), patients will be randomized either to complete bedrest with negative tilt vs. those who will undergo daily horizontal treadmill exercise to replace the calcaneus impact measured pre-bedrest in the same subjects. This provides an excellent opportunity for assessing the impact of this degree in type of exercise on the cardiovascular system.

The specific aims of this synergistic study will be answered as follows:

Specific Aim 1: To assess the impact of bedrest on cardiac atrophy, stiffening of the left ventricular diastolic pressure volume curve, and exercise tolerance and ventricular mechanics and demonstrate at least partial prevention of these changes with the proposed exercise prescription.

LV mass will be measured by MRI pre- and post-bedrest and by 3D echo at bedrest stages. Two-way linear regression will be used to determine change over time in LV mass and to compare the response to exercise. Similarly, exercise capacity will be analyzed. Among the LV mechanics parameters that will be available for analysis at all 3 data acquisition points are: (resting) LV end-diastolic and end-systolic volume, left atrial volume, transmitral E and A waves and E-wave deceleration time, Doppler tissue annular E, A, and S waves, radial, circumferential, and longitudinal strain at the midventricular level, LV torsion and peak untwisting rate, and color M-mode IVPG. These same parameters will also be available for analysis during low-level (HR 100) bicycle exercise.

Specific Aim 2: To demonstrate the ability of novel echocardiographic indices of ventricular function at rest (strain, torsion, IVPG) to predict functional capacity and response to exercise.

Strain, torsion, and IVPG will be assessed at all stages and correlated with changes in cardiac atrophy parameters (LV mass and volumes).

Specific Aim 3: To test whether pre/post bedrest MRI examinations can be co-registered with bedrest 3D echocardiographic exams to track atrophy and altered cardiac anatomy. The ability of detailed 3D ground examinations to be compared precisely with in-flight 3D echos is a key goal of autonomous medical care system for expedition class missions.

02

Conditions studied

  • Bedrest

Keywords

  • effect of bedrest
  • cardiac atrophy
03

In context

Lead sponsor

The Cleveland Clinic is the lead sponsor of 818 studies on the registry; 118 are open to participants now.

Of its 89 completed or terminated interventional studies of FDA-regulated products, 72 (81%) have results posted.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
Yes
Sampling method
Non-probability sample

Study population

Normal volunteers

Inclusion criteria

  • age 18 or older
  • Currently participating in bed rest study

Exclusion criteria

Exclusion Criteria

-unable to maintain bedrest

05

Study design

Observational model
Case-only
Time perspective
Prospective
Enrollment
6 participants (actual)
06

What researchers measure

Primary outcomes

  1. 2D and 3D echocardiography

    Time frame: 12 weeks

Secondary outcomes

  1. MRI

    Time frame: 12 weeks

07

Study locations

1 site
  • Cleveland Clinic
    Cleveland, Ohio 44195, United States
08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Jan 27, 2017, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT00598494
Lead sponsor
The Cleveland Clinic
Collaborators
National Space Biomedical Research Institute
Responsible party
Sponsor
First posted
Jan 22, 2008
Start date
Feb 2007
Primary completion
Jul 2008
Completion
Jul 2008
Last update
Jan 27, 2017

Study contacts

Jim Thomas, MD
principal investigator · The Cleveland Clinic

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is terminated, as verified in Jan 2017. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion